Recorded Chinese product: 刺五加注射液刺五加注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 多多药业有限公司Chinese legal name: 多多药业有限公司
主要成分Active Ingredients
- 刺五加Ciwu Jia
药物知识说明
刺五加是一种在国家药监局注册认定的药品。该药品含有刺五加-c7955d77等成分。
该药品关联的活性成分包括：刺五加Ciwu Jia。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：多多药业有限公司Chinese legal name: 多多药业有限公司。
您可以探索含有相同成分的其他药品：刺五加-c7955d77成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 刺五加注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 刺五加Ciwu Jia.
Manufacturers recorded for this product: 多多药业有限公司Chinese legal name: 多多药业有限公司.
Explore other medicines containing the same ingredient: 刺五加 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 刺五加注射液Recorded Chinese product: 刺五加注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 每支20ml(含总黄酮100mg)Recorded Chinese specification: 每支20ml(含总黄酮100mg)
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 多多药业有限公司Chinese legal name: 多多药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20033181
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20033181
Manufacturer
Chinese legal name: 多多药业有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字Z20033181
生产企业
多多药业有限公司(国产)
功能主治
平补肝肾，益精壮骨。用于肝肾不足所致的短暂性脑缺血发作，脑动脉硬化，脑血栓形成，脑栓塞等。亦用于冠心病，心绞痛合并神经衰弱和更年期综合症等。
用法用量
静脉滴注，一次300～500mg，一日1～2次，20ml规格的注射液可按每次公斤体重7mg，加入生理盐水或5%～10%葡萄糖注射液中。
不良反应
(1)静脉滴注过程中偶见轻微血管疼痛，减慢滴速后疼痛感可消失。
禁忌
(1)对本品有过敏史的患者禁止使用。 (2)高敏体质或对同类产品有严重过敏史者禁止使用。 (3)本品严禁混合配伍。
注意事项
(1)用药前要认真询问病人的过敏史，对过敏体质者应慎用，如确需使用应注意监护。
贮藏
密封，遮光，置阴凉处（不超过20℃）。
规格
每支20ml(含总黄酮100mg)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.